Frontiers in Endocrinology | Cancer Endocrinology

Original Research

Accepted on 17 Feb 2025

Aspartate beta-hydroxylase (ASPH) is a prognostic factor in gallbladder cancer with the function of promoting tumorigenesis and chemoresistance

in Cancer Endocrinology

Luo Yuan
Huang Yunpeng
Li Xiong
Yu Wen
Wang Yongxiang

Frontiers in Endocrinology

doi 10.3389/fendo.2025.1452345

Original Research

Accepted on 14 Feb 2025

Construction and validation of novel nomograms based on the log odds of positive lymph nodes to predict the prognosis of papillary thyroid cancer: a retrospective cohort study

in Cancer Endocrinology

Saisai Jing
Jiazhao Song
Yupeng Di
Jiajia Xiao
Jianke Ma
Zimiao Wu

Frontiers in Endocrinology

doi 10.3389/fendo.2025.1411426

Original Research

Published on 13 Feb 2025

Causal relationship between hormone levels and lung cancer: a Mendelian randomization study

in Cancer Endocrinology

Zhiying Feng
Jingmin Fu
Kangyu Wang
Jiaxin Yang
Xuelian Jiang
Qiong Wu

Frontiers in Endocrinology

doi 10.3389/fendo.2025.1462531

224 views

Original Research

Published on 13 Feb 2025

Global disease burden of breast cancer attributable to high fasting plasma glucose: a comprehensive analysis from the global burden of disease study

in Cancer Endocrinology

Jing Zhang
Jiawei He
Yunyan Lu
Tian Lan

Frontiers in Endocrinology

doi 10.3389/fendo.2025.1498207

263 views

Original Research

Accepted on 12 Feb 2025

Wnt/-catenin pathway activation is associated with glucocorticoid secretion in adrenocortical carcinoma, but not directly with immune cell infiltration

in Cancer Endocrinology

Tanja Maier
Laura-Sophie Landwehr
Alexandra Triebig
Stefan Kircher
Marc P Schauer
Thomas Knösel
Silviu Sbiera
Petra Zimmermann
Martin Reincke
Isabel Weigand

Frontiers in Endocrinology

doi 10.3389/fendo.2025.1502117

Original Research

Accepted on 11 Feb 2025

Identification of a novel prognostic and therapeutic prediction model in clear cell renal carcinoma based on Renin-angiotensin system related genes

in Cancer Endocrinology

Qinzheng Chang
Shuo Zhao
Jiajia Sun
Wei Guo
Lin Yang
Laiyuan Qiu
Nianzhao Zhang
Yidong Fan
Jikai Liu

Frontiers in Endocrinology

doi 10.3389/fendo.2025.1521940

Mini Review

Published on 11 Feb 2025

CAR-T therapy for endocrine neoplasms: novel targets and combination of therapies

in Cancer Endocrinology

Fang Wang
Ruiqi Zhang
Zhaokai Zhou
Run Shi
Fu Peng
Yudi Xu
Shuai Yang
Zhan Wang
Pengpeng Zhang
Rui Tu

Frontiers in Endocrinology

doi 10.3389/fendo.2025.1517525

227 views

Original Research

Published on 10 Feb 2025

SHP2 is essential for the progesterone-promoted proliferation and migration in breast cancer cell lines

in Cancer Endocrinology

Hui-Chen Wang
Wen-Sen Lee

Frontiers in Endocrinology

doi 10.3389/fendo.2025.1523589

197 views

Original Research

Published on 10 Feb 2025

Genome-wide transcriptome analysis and drug target discovery reveal key genes and pathways in thyroid cancer metastasis

in Cancer Endocrinology

Minjing Zou
Amal Qattan
Monther Al-Alwan
Hazem Ghebeh
Naif Binjumah
Latifa Al-Haj
Khalid S. A. Khabar
Abdulmohsen Altaweel
Falah Almohanna
Abdullah M. Assiri

Frontiers in Endocrinology

doi 10.3389/fendo.2025.1514264

254 views

Original Research

Accepted on 07 Feb 2025

Fatty acid metabolism influences the immune microenvironment in papillary thyroid cancer and identifies SCD as a novel biomarker

in Cancer Endocrinology

Bingbing Shen
Yu Zhang
Yan Tie

Frontiers in Endocrinology

doi 10.3389/fendo.2025.1534393

Original Research

Accepted on 06 Feb 2025

Identification of the high-risk population facing early death in older patients with primary intracranial glioma: a retrospective cohort study

in Cancer Endocrinology

Gui-Jun Lu
Ying Zhao
Rui Huang

Frontiers in Endocrinology

doi 10.3389/fendo.2025.1546530

Original Research

Accepted on 04 Feb 2025

Machine Learning-Driven Ultrasound Radiomics for Assessing Axillary Lymph Node Burden in Breast Cancer

in Cancer Endocrinology

Si-Rui Wang
Tong Zhu
Cao Chunli
Jin Li Wang
Wen-Xiao Li
Jun Li
Jixue Hou

Frontiers in Endocrinology

doi 10.3389/fendo.2025.1548888

Review

Accepted on 03 Feb 2025

Crosstalk of TGF-β and somatostatin signaling in adenocarcinoma and neuroendocrine tumors of the pancreas: a brief review

in Cancer Endocrinology

Hendrik Ungefroren
Harpal Singh Randeva
Hendrik Lehnert
Jörg Schrader
Jens Uwe Marquardt
Björn Konukiewitz
Ralf Hass

Frontiers in Endocrinology

doi 10.3389/fendo.2025.1511348

Original Research

Accepted on 03 Feb 2025

Prognostic Performance of Examined Lymph Nodes, Lymph Node Ratio, and Positive Lymph Nodes in Gastric Cancer: A Competing Risk Model Study

in Cancer Endocrinology

Xiao Gu
Yaqi Du

Frontiers in Endocrinology

doi 10.3389/fendo.2025.1434999

Original Research

Published on 24 Jan 2025

Molecular testing stratifies the risk of structural recurrence in high risk differentiated thyroid cancer: a retrospective cohort study

in Cancer Endocrinology

Jie Liu
Wensi Gao
Xiong Zheng
Shuping Wu
Yi Shi
Feng Wang
Yu Wu

Frontiers in Endocrinology

doi 10.3389/fendo.2025.1508404

463 views

Review

Published on 24 Jan 2025

Interaction of GPER-1 with the endocrine signaling axis in breast cancer

in Cancer Endocrinology

Luis Molina Calistro
Yennyfer Arancibia
Marcela Alejandra Olivera
Sigrid Domke
Rodrigo Flavio Torres

Frontiers in Endocrinology

doi 10.3389/fendo.2025.1494411

608 views

Navigation group

Articles

Aspartate beta-hydroxylase (ASPH) is a prognostic factor in gallbladder cancer with the function of promoting tumorigenesis and chemoresistance

Construction and validation of novel nomograms based on the log odds of positive lymph nodes to predict the prognosis of papillary thyroid cancer: a retrospective cohort study

Causal relationship between hormone levels and lung cancer: a Mendelian randomization study

Global disease burden of breast cancer attributable to high fasting plasma glucose: a comprehensive analysis from the global burden of disease study

Wnt/-catenin pathway activation is associated with glucocorticoid secretion in adrenocortical carcinoma, but not directly with immune cell infiltration

Identification of a novel prognostic and therapeutic prediction model in clear cell renal carcinoma based on Renin-angiotensin system related genes

CAR-T therapy for endocrine neoplasms: novel targets and combination of therapies

SHP2 is essential for the progesterone-promoted proliferation and migration in breast cancer cell lines

Genome-wide transcriptome analysis and drug target discovery reveal key genes and pathways in thyroid cancer metastasis

Fatty acid metabolism influences the immune microenvironment in papillary thyroid cancer and identifies SCD as a novel biomarker

Identification of the high-risk population facing early death in older patients with primary intracranial glioma: a retrospective cohort study

Machine Learning-Driven Ultrasound Radiomics for Assessing Axillary Lymph Node Burden in Breast Cancer

Crosstalk of TGF-β and somatostatin signaling in adenocarcinoma and neuroendocrine tumors of the pancreas: a brief review

Prognostic Performance of Examined Lymph Nodes, Lymph Node Ratio, and Positive Lymph Nodes in Gastric Cancer: A Competing Risk Model Study

Molecular testing stratifies the risk of structural recurrence in high risk differentiated thyroid cancer: a retrospective cohort study

Interaction of GPER-1 with the endocrine signaling axis in breast cancer